Among the several pathways implicated in the oncogenic process, PI3K/AKT/mTOR is particularly relevant due to its constitutive activation in many patients with HCC and its association with the more severe forms of the disease [8]. This evidence concerns the gene MTOR and hepatocellular carcinoma.